The IRA caps out-of-pocket spending for insulin products. What would be the likely effect of this component of the IRA on the future availability of insulin products, other things equal, if these price reductions were large? Take a simple stand and briefly defend it. Think about the "optics" or the politics of these parts of the IRA. Do you think that powerful voter blocs like the American Association of Retired Persons (AARP) would lobby to repeal these parts of the IRA? If not, which groups would lobby for repeal?